Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Brief Summary: Intravitreal injections of pegaptanib every 4 weeks will be efficacious in treating Diabetic Macular Edema (DME), as compared to injections every 6 weeks.